NCT00912288 - A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions

Alzheimer Disease

Interventions

DRUG

Dimebon 20 mg po TID

Dimebon 10 mg po TID for 1 week followed by Dimebon 20 mg TID for 25 weeks

DRUG

Placebo po TID

Placebo (matched to Dimebon) po for 26 weeks

Trial Locations (47)

1083

Pfizer Investigational Site, Budapest

5700

Pfizer Investigational Site, Gyula

8000

Pfizer Investigational Site, Székesfehérvár

13210

Pfizer Investigational Site, Syracuse

13581

Pfizer Investigational Site, Berlin

14620

Pfizer Investigational Site, Rochester

17190

Pfizer Investigational Site, Salt

19401

Pfizer Investigational Site, Norristown

33407

Pfizer Investigational Site, West Palm Beach

33445

Pfizer Investigational Site, Delray Beach

34390

Pfizer Investigational Site, Istanbul

34601

Pfizer Investigational Site, Brooksville

38018

Pfizer Investigational Site, Cordova

40503

Pfizer Investigational Site, Lexington

41071

Pfizer Investigational Site, Seville

41400

Pfizer Investigational Site, Kocaeli

44892

Pfizer Investigational Site, Bochum

46260

Pfizer Investigational Site, Indianapolis

48993

Pfizer Investigational Site, Algorta, Getxo

53562

Pfizer Investigational Site, Middleton

55131

Pfizer Investigational Site, Mainz

55139

Pfizer Investigational Site, Samsun

80218

Pfizer Investigational Site, Denver

82007

Pfizer Investigational Site, Bratislava

85006

Pfizer Investigational Site, Phoenix

89312

Pfizer Investigational Site, Günzburg

90720

Pfizer Investigational Site, Los Alamitos

91316

Pfizer Investigational Site, Encino

92626

Pfizer Investigational Site, Costa Mesa

92663

Pfizer Investigational Site, Newport Beach

92660-2452

Pfizer Investigational Site, Newport Beach

06510

Pfizer Investigational Site, New Haven

01201

Pfizer Investigational Site, Pittsfield

08540

Pfizer Investigational Site, Princeton

02914

Pfizer Investigational Site, East Providence

R3M 0X9

Pfizer Investigational Site, Winnipeg

H4H-1R3

Pfizer Investigational Site, Montreal

G2B 5S1

Pfizer Investigational Site, Québec

04107

Pfizer Investigational Site, Leipzig

09648

Pfizer Investigational Site, Mittweida

2700-276

Pfizer Investigational Site, Amadora

3000-548

Pfizer Investigational Site, Coimbra

071 01

Pfizer Investigational Site, Michalovce

04801

Pfizer Investigational Site, Rožňava

01001

Pfizer Investigational Site, Žilina

08014

Pfizer Investigational Site, Barcelona

08041

Pfizer Investigational Site, Barcelona